St. Lucia health authorities have reported that it had received confirmation from the Caribbean Public Health Agency (CARPHA) of five cases of the United Kingdom strain of COVID-19 in the island.
It said two cases of the SARS-Co-V-2 British variant diagnosed in the country were British nationals who were diagnosed on December 17 and December 23, 2020. The other three cases are St. Lucian nationals who were also diagnosed that month.
All five cases have since made a full recovery, the Ministry said.
“This new situation further emphasizes the need for strict adherence to all protocols recommended thus far and to ensure increased vigilance at all levels where risk has been identified. The Ministry of Health and Wellness will continue monitoring the situation and recommendations will be made as needed, guided by the science to reduce the impact of COVID-19 on our population,” it added.
“We continue to monitor both the global and regional situation as we assess our risks and make recommendations. We also continue to monitor closely and use best practices implemented as we strengthen the existing national protocols.”
On December 14, 2020, the UK Public Health Agency reported a COVID-19 variant that had been in circulation from September 20, 2020, within the UK.
The Trinidad-based CARPHA had requested that positive cases with high viral loads be sent to their laboratories for gene sequencing for surveillance of this new variant of the virus in the region.
The new strain has been detected in Denmark, the Netherlands, Belgium and Australia but the risk of importation into the Caribbean and rest of the world had rated as high due to incoming travel from the United Kingdom and Europe.
Studies conducted in the United Kingdom on this new variant of the virus suggest that it increases the rate at which the virus spreads. This is estimated as increasing as much as up to 70 percent.
The United Kingdom has noted increased levels of transmission and spread in the areas where the variant strain has been found. However, there is no evidence at this point of more severe cases associated with the new variant or it reducing the effectiveness of the COVID-19 vaccine.